Trial Outcomes & Findings for Comparison Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy (NCT NCT02897531)

NCT ID: NCT02897531

Last Updated: 2025-03-05

Results Overview

The cumulative recovery rate is defined as the percentage of patients who are satisfied with all aspects of recovery time. Recovery time includes the following: 1. Tolerance of diet for 24hours 2. Analgesic-free status (oral or intravenous (IV) analgesic drugs not necessary after cessation of patient-controlled analgesia (PCA)), 3. Safe ambulation (ambulation of 600m without assistance), 4. Afebrile status without major complications (fever was defined as body temperature greater than 37.2°C at axilla).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

130 participants

Primary outcome timeframe

at 7 days after operation

Results posted on

2025-03-05

Participant Flow

During the study period, 201 patients met the inclusion criteria. Excluding patients who required combined operations (n = 18), and patients who could not undergo laparoscopic surgery or an ERAS protocol due to previous medical/surgical history (n = 22), 161 patients were invited to participate in the study. Of these, 130 provided informed consent and were randomized to either the ES or the SS group (n = 65 each)

Participant milestones

Participant milestones
Measure
ES Anastomosis
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Overall Study
STARTED
65
65
Overall Study
COMPLETED
65
65
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Total
n=130 Participants
Total of all reporting groups
Age, Continuous
64.8 years
STANDARD_DEVIATION 10.6 • n=65 Participants
59.7 years
STANDARD_DEVIATION 11.5 • n=65 Participants
62.2 years
STANDARD_DEVIATION 11.1 • n=130 Participants
Sex: Female, Male
Female
42 Participants
n=65 Participants
32 Participants
n=65 Participants
74 Participants
n=130 Participants
Sex: Female, Male
Male
23 Participants
n=65 Participants
33 Participants
n=65 Participants
56 Participants
n=130 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
South Korea
65 participants
n=65 Participants
65 participants
n=65 Participants
130 participants
n=130 Participants
American Society of Anesthesiology
ASA 1
18 participants
n=65 Participants
22 participants
n=65 Participants
40 participants
n=130 Participants
American Society of Anesthesiology
ASA 2
39 participants
n=65 Participants
33 participants
n=65 Participants
72 participants
n=130 Participants
American Society of Anesthesiology
ASA 3
8 participants
n=65 Participants
10 participants
n=65 Participants
18 participants
n=130 Participants

PRIMARY outcome

Timeframe: at 7 days after operation

The cumulative recovery rate is defined as the percentage of patients who are satisfied with all aspects of recovery time. Recovery time includes the following: 1. Tolerance of diet for 24hours 2. Analgesic-free status (oral or intravenous (IV) analgesic drugs not necessary after cessation of patient-controlled analgesia (PCA)), 3. Safe ambulation (ambulation of 600m without assistance), 4. Afebrile status without major complications (fever was defined as body temperature greater than 37.2°C at axilla).

Outcome measures

Outcome measures
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Cumulative Recovery Rate
100 percentage of participants
100 percentage of participants

SECONDARY outcome

Timeframe: at discharge from hospital, an average of 1 week

Time(days) from operation to discharge

Outcome measures

Outcome measures
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Postoperative Hospital Stay
5 days
Interval 5.0 to 7.0
6 days
Interval 5.0 to 7.0

SECONDARY outcome

Timeframe: at 30 days

Includes any minor complication (ileus, wound infection) to major complications requiring re-intervention

Outcome measures

Outcome measures
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Postoperative Complications
11 events
8 events

SECONDARY outcome

Timeframe: at discharge from hospital, an average of 1 week

the number of patients who failed to adhere to the ERAS protocol

Outcome measures

Outcome measures
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Failure Rate of the Enhanced Recovery Program
7 participants
5 participants

SECONDARY outcome

Timeframe: at 30 days

the number of patients who were re-admitted after discharge within 1 month after surgery

Outcome measures

Outcome measures
Measure
ES Anastomosis
n=65 Participants
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 Participants
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Readmission Rate Within 1 Month After Surgery
3 participants
2 participants

Adverse Events

ES Anastomosis

Serious events: 0 serious events
Other events: 8 other events
Deaths: 0 deaths

SS Anastomosis

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
ES Anastomosis
n=65 participants at risk
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
SS Anastomosis
n=65 participants at risk
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
Gastrointestinal disorders
ileus
3.1%
2/65 • Number of events 2 • up to 3 year for each participant
3.1%
2/65 • Number of events 2 • up to 3 year for each participant
Gastrointestinal disorders
Gastrointestinal bleeding
0.00%
0/65 • up to 3 year for each participant
1.5%
1/65 • Number of events 1 • up to 3 year for each participant
Respiratory, thoracic and mediastinal disorders
Pneumonia
1.5%
1/65 • Number of events 1 • up to 3 year for each participant
0.00%
0/65 • up to 3 year for each participant
Infections and infestations
Surgical site infection
7.7%
5/65 • Number of events 5 • up to 3 year for each participant
4.6%
3/65 • Number of events 3 • up to 3 year for each participant

Additional Information

Sung-Bum Kang, MD, PhD

Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital

Phone: +82-031-787-7093

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place